1. Home
  2. BCAB vs KSCP Comparison

BCAB vs KSCP Comparison

Compare BCAB & KSCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • KSCP
  • Stock Information
  • Founded
  • BCAB 2007
  • KSCP 2013
  • Country
  • BCAB United States
  • KSCP United States
  • Employees
  • BCAB N/A
  • KSCP N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • KSCP Telecommunications Equipment
  • Sector
  • BCAB Health Care
  • KSCP Telecommunications
  • Exchange
  • BCAB Nasdaq
  • KSCP Nasdaq
  • Market Cap
  • BCAB 22.3M
  • KSCP 29.3M
  • IPO Year
  • BCAB 2020
  • KSCP 2022
  • Fundamental
  • Price
  • BCAB $0.41
  • KSCP $5.58
  • Analyst Decision
  • BCAB Buy
  • KSCP Strong Buy
  • Analyst Count
  • BCAB 2
  • KSCP 3
  • Target Price
  • BCAB $1.00
  • KSCP $17.00
  • AVG Volume (30 Days)
  • BCAB 421.1K
  • KSCP 199.3K
  • Earning Date
  • BCAB 05-06-2025
  • KSCP 05-14-2025
  • Dividend Yield
  • BCAB N/A
  • KSCP N/A
  • EPS Growth
  • BCAB N/A
  • KSCP N/A
  • EPS
  • BCAB N/A
  • KSCP N/A
  • Revenue
  • BCAB $11,000,000.00
  • KSCP $11,468,000.00
  • Revenue This Year
  • BCAB N/A
  • KSCP $19.31
  • Revenue Next Year
  • BCAB N/A
  • KSCP $37.58
  • P/E Ratio
  • BCAB N/A
  • KSCP N/A
  • Revenue Growth
  • BCAB N/A
  • KSCP N/A
  • 52 Week Low
  • BCAB $0.24
  • KSCP $2.45
  • 52 Week High
  • BCAB $2.53
  • KSCP $28.57
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 50.31
  • KSCP 52.02
  • Support Level
  • BCAB $0.37
  • KSCP $5.43
  • Resistance Level
  • BCAB $0.42
  • KSCP $6.49
  • Average True Range (ATR)
  • BCAB 0.04
  • KSCP 0.53
  • MACD
  • BCAB -0.01
  • KSCP -0.03
  • Stochastic Oscillator
  • BCAB 35.88
  • KSCP 32.00

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About KSCP Knightscope Inc.

Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.

Share on Social Networks: